In this study, we confirmed that OCPs and plasma RANKL levels were significantly elevated in psoriatic patients compared to the healthy controls, reinforcing the concept of a “pro-osteoclastogenic march” in psoriasis. This evidence concerns the gene TNFSF11 and psoriasis.